New Rx Treats Common Blood Cancer
The US Food and Drug Administration (FDA) has approved a new medication to treat a common type of blood cancer.
A Change in REMS Requirements
The US Food and Drug Administration (FDA) has lifted the Risk Evaluation and Mitigation Strategy (REMS) requirements for certain medications used to treat anemia.
Boosting Leukemia Survival
Umbilical cord blood transplants may lead to high survival in patients with leukemia who are at high risk for relapse post-transplant, a new study found.
Got Peripheral Artery Disease?
Patients with atherosclerotic peripheral arterial disease (PAD) saw improved results from revascularization to treat intermittent claudication (IC), a common symptom of PAD, a new study found.
Anemia, Stroke and Death Risk
Anemia, a condition marked by a low red blood cell count, may increase risk of death in those who have had a stroke, according to a new study.
A New Job for Opdivo
The US Food and Drug Administration (FDA) has approved a new treatment for Hodgkin lymphoma.
Targeted Leukemia Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved the first treatment to specifically target the B-cell lymphoma 2 (BCL-2) protein found in patients with chronic lymphocytic leukemia (CLL).
Hemophilia A Treatment Gets Green Light
The US Food and Drug Administration (FDA) has approved a new treatment for hemophilia A.
A New Formulation for Melphalan
The US Food and Drug Administration (FDA) approved a new formula of melphalan under the brand name Evomela to treat patients with multiple myeloma.
Another Hemophilia Treatment Option
Patients with hemophilia B, a rare, inherited bleeding disorder, may soon have another treatment option.